What is DemeTECH?
DemeTECH Corporation operates as a specialized manufacturer of high-grade personal protective equipment, with a core focus on surgical masks and N95 respirators. By strictly utilizing American-made materials, the company addresses the systemic vulnerabilities in the healthcare supply chain that were exposed during recent global health crises. Their product portfolio, which spans ASTM Level 3 surgical masks and specialized respiratory protection for both adults and children, positions them as a vital infrastructure partner for healthcare providers and commercial enterprises alike. The company's commitment to domestic manufacturing serves as a competitive moat, ensuring quality control and supply chain resilience that international competitors often struggle to replicate.
How much funding has DemeTECH raised?
DemeTECH has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in DemeTECH
PPP
Public-Private Partnership
What's next for DemeTECH?
With this late-stage financing, DemeTECH is well-positioned to scale its industrial footprint and optimize its production throughput. The strategic allocation of these funds will likely focus on expanding manufacturing capacity to meet sustained demand from institutional healthcare clients and the broader public sector. As the company matures, the focus will shift toward long-term operational efficiency and the potential diversification of its medical device portfolio. By leveraging its established reputation for quality and domestic reliability, DemeTECH is poised to maintain its market leadership, ensuring that critical PPE remains accessible while insulating its operations from the logistical disruptions that frequently plague globalized manufacturing models.
See full DemeTECH company page
